Agent for reducing visceral fat weight
US-2016243086-A1 · Aug 25, 2016 · US
Drug for treatment of nonalcoholic fatty liver disease
US2016136138A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016136138-A1 |
| Application number | US-201414903114-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jul 9, 2014 |
| Priority date | Jul 10, 2013 |
| Publication date | May 19, 2016 |
| Grant date | — |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides a compound useful in the prevention and treatment of nonalcoholic fatty liver disease. The invention relates to a drug for the prevention and/or treatment of nonalcoholic fatty liver disease, the drug having as an active ingredient (R)-2-[3-[[N-(benzoxazol-2-yl)-N-3-(4-methoxyphenoxy)propyl]aminomethyl]phenoxy]butyric acid, a salt thereof, or a solvate of these.
First claim
Opening claim text (preview).
1 - 4 . (canceled) 5 . A method for preventing and/or treating nonalcoholic fatty liver disease, comprising: administering an effective amount of (R)-2-[3-[[N-(benzoxazol-2-yl)-N-3-(4-methoxyphenoxy)propyl]aminomethyl]phenoxy]butyric acid or a salt thereof, or a solvate thereof to a patient in need thereof. 6 . The method of claim 5 , wherein the nonalcoholic fatty liver disease is nonalcoholic steatohepatitis. 7 . A method for suppressing or reducing fat deposition in the liver, comprising: administering an effective amount of (R)-2-[3-[[N-(benzoxazol-2-yl)-N-3-(4-methoxyphenoxy)propyl]aminomethyl]phenoxy]butyric acid or a salt thereof, or a solvate thereof to a patient in need of suppression or reduction of fat deposition in the liver 8 . A method for suppressing the increase in the number of Kupffer cells in the liver or reducing the number of Kupffer cells in the liver, comprising: administering an effective amount of (R)-2-[3-[[N-(benzoxazol-2-yl)-N-3-(4-methoxyphenoxy)propyl]aminomethyl]phenoxy]butyric acid or a salt thereof, or a solvate thereof to a patient in need of suppression of the increase in the number of Kupffer cells in the liver or in need of reduction of the number of Kupffer cells in the liver.
Assignees
Inventors
Classifications
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
- A61P1/16Primary
for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics · CPC title
- A61K31/423Primary
condensed with carbocyclic rings · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US2016136138A1 cover?
- The present invention provides a compound useful in the prevention and treatment of nonalcoholic fatty liver disease. The invention relates to a drug for the prevention and/or treatment of nonalcoholic fatty liver disease, the drug having as an active ingredient (R)-2-[3-[[N-(benzoxazol-2-yl)-N-3-(4-methoxyphenoxy)propyl]aminomethyl]phenoxy]butyric acid, a salt thereof, or a solvate of these.
- Who is the assignee on this patent?
- Kowa Co
- What technology area does this patent fall under?
- Primary CPC classification A61P1/16. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Thu May 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).